Skip to main content
Fig. 1 | Molecular Neurodegeneration

Fig. 1

From: Neuroprotection by WldS depends on retinal ganglion cell type and age in glaucoma

Fig. 1

Genotype Confirmation, IOP Elevation, and RGC Density Measurements. A Quantitative RT-PCR measurements of WldS transgene in genomic DNA from WldS null (WldS−/−), WldS heterozygous (WldS+/−), and WldS homozygous (WldS+/+) mice. Values are normalized against WT animals. B Agarose gel (2%) showing RT-PCR detection in the retina of WldS chimeric (a,b) and housekeeping GAPDH (c) transcripts from WldS+/+, WldS+/−, and WT mice. 1,2 indicates samples extracted from different mice. C Mean intraocular pressure (IOP) in WT (circles) and WldS+/+ (squares) mice before (day 0) and following (days ≥1) a single unilateral injection of polystyrene microbeads (gray symbols) or equivalent volume of saline (white symbols). D Microbead injection significantly elevated IOP in all genotypes (WT: 19.64 ± 1.82 vs. 14.81 ± 1.54 mmHg, p < 0.001; WldS+/+: 19.48 ± 1.98 vs. 14.23 ± 1.61 mmHg, p < 0.001). E Representative confocal images of whole-mount retinas from WT and WldS+/+ saline and microbead injected eyes immunolabeled against RBPMS (grayscale). Scale bar = 25 μm. F When quantified, we did not detect a significant difference in RBPMS+ RGCs regardless of genotype or IOP condition (p = 0.389). Statistics: Student’s t-test (D). One-Way ANOVA Tukey’s Post hoc (F). Data = mean ± SEM

Back to article page